EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Femoropopliteal Endovascular Intervention: A Review of the Current Landscape

Manasi Tannu iD, W Schuyler Jones iD, Rajesh V Swaminathan iD, Jennifer A Rymer iD, J Antonio Gutierrez iD

Circulation: Cardiovascular Interventions · 2025-05 · 18 (5)

DOI: 10.1161/circinterventions.124.014024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation: Cardiovascular Interventions, 2025-05. Verfasst von Manasi Tannu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Duke University Health System, Durham, NC (M.T., W.S.J., R.V.S., J.A.R., J.A.G.). Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Femoral Artery, Popliteal Artery, Endovascular Procedures. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Superficial femoral artery disease poses significant challenges in patients with peripheral artery disease due to its unique anatomic and physiological characteristics. While conservative measures remain the initial approach for chronic, stable symptoms, endovascular therapies have gained prominence due to their minimally invasive nature, expedited recovery times, and preservation of future treatment options when performed correctly. Options for endovascular interventions include balloon angioplasty (percutaneous transluminal angioplasty [standard], drug-coated balloon), stenting (bare metal, drug-eluting, covered stents), with or without adjunct therapy (atherectomy or intravascular lithotripsy). Randomized controlled trials have demonstrated superior outcomes with drug-coated balloons and drug-eluting stents over bare metal stents or percutaneous transluminal angioplasty alone, particularly in long, heavily calcified lesions. However, challenges such as in-stent restenosis, stent fracture, and in-stent thrombosis persist, driving ongoing innovation in device technology and drug formulations on devices. Emerging therapies such as bioresorbable scaffolds and percutaneous bypass devices offer promising alternatives. Further research is needed to refine treatment strategies, minimize risks, and optimize outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseFemoral ArteryPopliteal ArteryEndovascular ProceduresAngioplasty, BalloonHumansTreatment OutcomeStentsRisk FactorsDrug-Eluting StentsProsthesis DesignVascular PatencyVascular Access Devices

Stichwörter der Autor:innen

angioplastyatherectomyperipheral artery diseasestents

Autor:innen und Institutionen

  • Division of Cardiology, Duke University Health System, Durham, NC (M.T., W.S.J., R.V.S., J.A.R., J.A.G.).
  • Duke Clinical Research Institute, Durham, NC (M.T., W.S.J., J.A.R.).
  • Durham VA Medical Center, Durham, NC (R.V.S., J.A.G.).

ORCID-Profile: Manasi Tannu, W Schuyler Jones, Rajesh V Swaminathan, Jennifer A Rymer, J Antonio Gutierrez

Zitieren

APA

Tannu, M., Jones, W. S., Swaminathan, R. V., Rymer, J. A., & Gutierrez, J. A. (2025). Femoropopliteal Endovascular Intervention: A Review of the Current Landscape. Circulation: Cardiovascular Interventions, 18(5). https://doi.org/10.1161/circinterventions.124.014024

Vancouver

Tannu M, Jones WS, Swaminathan RV, Rymer JA, Gutierrez JA. Femoropopliteal Endovascular Intervention: A Review of the Current Landscape. Circulation: Cardiovascular Interventions. 2025;18(5). doi:10.1161/circinterventions.124.014024

BibTeX
@article{Tannu2025,
  author = {Tannu, Manasi and Jones, W Schuyler and Swaminathan, Rajesh V and Rymer, Jennifer A and Gutierrez, J Antonio},
  title = {Femoropopliteal Endovascular Intervention: A Review of the Current Landscape},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {5},
  doi = {10.1161/circinterventions.124.014024}
}
Kostenlos starten →